Exicure, Inc. Common Stock (XCUR)

Price$3.33

Value ScoreC

Growth ScoreF

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-39.61%

Price vs S&P 500 (4W)-6.52%

VGM Score30.87

Market Capitalization$19.84M

All Metrics

Book Value / Share (Quarterly)$0.62

P/TBV (Annual)242.39x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.34

Price vs S&P 500 (YTD)-52.08%

Net Profit Margin (TTM)-165.80%

EPS (TTM)$-0.77

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.77

Revenue Growth (5Y)-17.40%

EPS (Annual)$-0.79

ROI (Annual)-125.98%

Net Profit Margin (5Y Avg)-4559.15%

Cash / Share (Quarterly)$0.59

ROA (Last FY)-35.23%

EBITD / Share (TTM)$-0.57

ROE (5Y Avg)-283.38%

Operating Margin (TTM)-167.20%

Cash Flow / Share (Annual)$-1.34

P/B Ratio5.05x

P/B Ratio (Quarterly)8.77x

Net Income / Employee (Annual)$-618,200

EV / Revenue (TTM)32.18x

Net Interest Coverage (TTM)-1937.60x

ROA (TTM)-28.79%

EV / EBITDA (TTM)2.68x

EPS Incl Extra (Annual)$-0.79

Current Ratio (Annual)1.19x

Quick Ratio (Quarterly)1.04x

3-Month Avg Trading Volume0.02M

52-Week Price Return-67.18%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.02

P/S Ratio (Annual)39.67x

Asset Turnover (Annual)0.03x

52-Week High$10.80

Operating Margin (5Y Avg)-4551.11%

EPS Excl Extra (Annual)$-0.79

CapEx CAGR (5Y)-80.06%

Tangible BV CAGR (5Y)-5.67%

26-Week Price Return-23.68%

Quick Ratio (Annual)1.04x

13-Week Price Return-14.02%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.19x

Enterprise Value$16.09M

Revenue / Share Growth (5Y)-18.42%

Asset Turnover (TTM)0.05x

Book Value / Share Growth (5Y)-50.73%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-1938.60%

Cash / Share (Annual)$0.59

3-Month Return Std Dev68.63%

Net Income / Employee (TTM)$-618,200

ROE (Last FY)-125.98%

Net Interest Coverage (Annual)-391.44x

EPS Basic Excl Extra (Annual)$-0.79

Receivables Turnover (TTM)-49.20x

EV / Free Cash Flow (TTM)0.48x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.77

ROI (TTM)-63.62%

P/S Ratio (TTM)39.67x

Pretax Margin (5Y Avg)-4558.68%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.02

Price vs S&P 500 (52W)-95.39%

Year-to-Date Return-41.14%

5-Day Price Return13.52%

EPS Normalized (Annual)$-0.79

ROA (5Y Avg)-71.11%

Net Profit Margin (Annual)-1940.20%

Month-to-Date Return-5.06%

Cash Flow / Share (TTM)$0.67

EBITD / Share (Annual)$-0.58

Operating Margin (Annual)-2365.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-239.74%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.77

P/TBV (Quarterly)242.39x

P/B Ratio (Annual)8.77x

Pretax Margin (TTM)-165.80%

Book Value / Share (Annual)$0.62

Price vs S&P 500 (13W)-23.76%

Beta3.67x

P/FCF (Annual)82.66x

Revenue / Share (TTM)$0.00

ROE (TTM)-63.62%

52-Week Low$2.63

vGradeC

gGradeF

mGradeD

vgmGradeD

Show chart for

Analyst Recommendations

Oct 2022

Nov 2022

Dec 2022

Jan 2023

2.17

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
XCURExicure, Inc. Common Stock	C	F	D	$3.33
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Exicure Inc is an early-stage biotechnology company developing nucleic acid therapeutics targeting validated disease pathways. The company specializes in RNA-based therapeutic approaches to address unmet clinical needs.